|
Match
|
Document |
Document Title |
|
|
7618956 |
Reduction of hair growth
Mammalian hair growth is reduced by applying an agonist of farnesoid X receptor.
|
|
|
7615544 |
Method of improving cumulative embryo score and quantity of fertilized oocytes, increasing euploidy rate and of normalizing ovarian function using an androgen such as dehydroepiandrosterone
A method of improving cumulative embryo score may comprise administering an androgen to a human female, for example, DHEA, for at least about four consecutive months followed by harvesting and...
|
|
|
7608610 |
Pharmaceutical composition
A pharmaceutical composition comprising: (A) an androgen; (B) a cyclic enhancer of the type used in the compositions and methods claimed by U.S. Pat. No. 5,023,252 to Hsieh; and (C) a thickening...
|
|
|
7608609 |
Pharmaceutical composition
A pharmaceutical composition comprising: (A) an androgen; (B) a cyclic enhancer of the type used in the compositions and methods claimed by U.S. Pat. No. 5,023,252 to Hsieh; and (C) a thickening...
|
|
|
7608608 |
Pharmaceutical composition
A pharmaceutical composition comprising: (A) an androgen; (B) a cyclic enhancer of the type used in the compositions and methods claimed by U.S. Pat. No. 5,023,252 to Hsieh; and (C) a thickening...
|
|
|
7608607 |
Pharmaceutical composition
A pharmaceutical composition comprising: (A) an androgen; (B) a cyclic enhancer of the type used in the compositions and methods claimed by U.S. Pat. No. 5,023,252 to Hsieh; and (C) a thickening...
|
|
|
7608606 |
Pharmaceutical composition
A pharmaceutical composition comprising: (A) an androgen; (B) a cyclic enhancer of the type used in the compositions and methods claimed by U.S. Pat. No. 5,023,252 to Hsieh; and (C) a thickening...
|
|
|
7608605 |
Pharmaceutical composition
A pharmaceutical composition comprising: (A) an androgen; (B) a cyclic enhancer of the type used in the compositions and methods claimed by U.S. Pat. No. 5,023,252 to Hsieh; and (C) a thickening...
|
|
|
7601706 |
Bile-acid conjugates providing for sustained systemic concentration of drugs
This invention is directed to compounds that provide for sustained systemic concentrations of therapeutic or prophylactic agents following administration to animals. This invention is also directed...
|
|
|
7598235 |
Bile-acid conjugates for providing sustained systemic concentrations of drugs
This invention is directed to compounds that provide for sustained systemic concentrations of therapeutic or prophylactic agents following administration to animals. This invention is also directed...
|
|
|
7595348 |
Butyl lactate emulsions for the precipitation of water-insoluble drug nanoparticles
Emulsions for use in precipitating water-insoluble drug nanoparticles. The continuous phase of the emulsions include water and an external surfactant. The discontinuous phase of the emulsions...
|
|
|
7563565 |
Method of preparing bio-identical hormones
The embodied composition is a dose of bio-identical hormones in a solvent with a vasodilator, a hormone modulator, and a carrier for balancing and maintaining Cortisol level in a human. The dose...
|
|
|
7553877 |
Modulators of the glucocorticoid receptor
The present invention provides compounds of the formula
wherein A is of the formula
and X, Y, n, R 1 —R 25 are as described in the specification which are modulators of the...
|
|
|
7547687 |
Therapeutic treatment methods
The invention relates to the use of compounds to ameliorate or treat a condition such as a cystic fibrosis, neutropenia or other exemplified conditions. Exemplary compounds that can be used include...
|
|
|
7524836 |
Nitrooxyderivative steroidal compounds
Steroidal compounds or their salts having general formulas (I) and (II) wherein: s is an integer equal to 1 or 2, preferably s=2; b0=0 or 1; A=R—, wherein R is the steroidal drug radical, C and C...
|
|
|
7521438 |
Combination of loteprednol and β2-adrenoceptor agonists
The invention relates to a novel combination of a soft steroid, in particular loteprednol, and at least one β 2 adrenoceptor agonist for the simultaneous, sequential or separate treatment of...
|
|
|
7521068 |
Dry powder aerosols of nanoparticulate drugs
There invention discloses aqueous dispersions of nanoparticulate aerosol formulations, dry powder nanoparticulate aerosol formulation, propellant-based aerosol formulations, methods of using the...
|
|
|
7488722 |
Anxiolytic Marcgraviaceae compositions containing betulinic acid, betulinic acid derivatives, and methods
Pharmaceutical compositions for preventing or treating anxiety, comprising betulinic acid or derivatives thereof are provided. Methods for preventing or treating anxiety with betulinic acid or...
|
|
|
7482334 |
Therapeutic treatment methods
The invention relates to the use of compounds to ameliorate or treat a condition such as a cystic fibrosis, neutropenia or other exemplified conditions. Exemplary compounds that can be used include...
|
|
|
7473416 |
Medicaments for asthma treatment
A method and apparatus are disclosed for treating asthma and other respiratory conditions. A medicament comprising a surface active phospholipid (SAPL) is prepared in the form of a fine powder and...
|
|
|
7470433 |
Formulations for transdermal or transmucosal application
The present invention relates generally to formulations for transdermal or transmucosal administration of an active agent such as estradiol. The invention is a substantially malodorous-free and...
|
|
|
7452556 |
Compositions for the treatment of pilosebaceous gland inflammations comprising aluminum fluoride
The present invention relates to compositions for the treatment of pilosebaceous gland inflammations, especially of the hair follicle and its appendages, in particular of Acne Vulgaris and...
|
|
|
7431916 |
Administration of medicinal dry powders
A method of administering a metered dry powder combined dose of finely divided dry medication powders is disclosed, wherein said method comprises providing a relative motion between a nozzle of a...
|
|
|
7429576 |
Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
Novel methods for the medical treatment and/or inhibition of the development of osteoporosis, breast cancer, hypercholesterolemia, hyperlipidemia or atherosclerosis in susceptible warm-blooded...
|
|
|
7422756 |
Skin preparation
The invention concerns a skin preparation for moistening human skin comprising a combination of a component A and a component B, wherein A includes at least two saturated C 9 -C 31 fatty acids...
|
|
|
7417051 |
Medicaments comprising betamimetics and a novel anticholinergic
A pharmaceutical composition comprising:
(a) a salt of formula 1
wherein:
X − is an anion with a single negative charge; and (b) a betamimetic 2,
or a solvate or hydrate thereof,...
|
|
|
7414042 |
Method and composition for selectively inhibiting melanoma
Compositions and methods are disclosed for treating melanoma wherein a betulinic acid derivative is the active compound in the composition to be administered. The compositions are optionally...
|
|
|
7410958 |
Triterpene quaternary salts as biologically active surfactants
The invention provides novel compounds that are quaternary amine derivatives of betulin and other triterpenes. The compounds have antibacterial, antifungal, and surfactant properties.
|
|
|
7384916 |
Methods and compositions for preventing and treating aging or photodamaged skin
Disclosed are methods for treating aging and photodamaged skin employing topical application of compositions which comprise at least one peptide manganese complex. Also disclosed are methods...
|
|
|
7381717 |
Anti-HIV agents with dual sites of action
The present invention provides compounds of the general structure:
which are substituted at the 3 and 28 positions, along with pharmaceutical formulations containing the same and methods of...
|
|
|
7371741 |
Estradiol derivatives and pharmaceutical compositions using same
Compositions and methods for treating mammalian disease characterized by undesirable angiogenesis by administering compounds of the general formula:
wherein the variables are defined in the...
|
|
|
7354608 |
Bio-identical hormones and method of use
The embodied composition is an evening dose of bio-identical hormones in a solvent with a vasodilator, a hormone modulator, and a carrier for balancing and maintaining Cortisol level in a human....
|
|
|
7351699 |
Use of DHEA or precursors or metabolic derivatives thereof as a depigmenting agent
The use of DHEA or at least one of its biological precursors or of its metabolic derivatives in or for the manufacture of a composition for topical application to the skin, as a pigmentation...
|
|
|
7335371 |
Combinations for the treatment of inflammatory disorders
The invention features methods and compositions for the treatment of immunonflammatory disorders.
|
|
|
7332180 |
Transdermal therapeutic system for administering non-steroidal antiphlogistic agents containing carboxyl groups, and a method for the production of the same
A transdermal therapeutic system (TTS) with a content of at least one active substance from the group of the carboxyl group-containing non-steroidal antirheumatics, which has a backing layer ( 1 ),...
|
|
|
7320968 |
Pharmaceutical composition
A pharmaceutical composition comprising: (A) an androgen; (B) a cyclic enhancer of the type used in the compositions and methods claimed by U.S. Pat. No. 5,023,252 to Hsieh; and (C) a thickening...
|
|
|
7312205 |
Methods and compositions for inhibiting tumor growth
The present invention relates to novel betulinic acid derivatives with increased activity for the treatment of carcinomas and HIV diseases, a method for preparing such novel betulinic acid...
|
|
|
7235255 |
Biological bioadhesive compositions and methods of preparation and use
The present invention relates generally to the preparation and use of biological tissue adhesives which rely on combining fibrinogen and thrombin. More particularly, the present invention relates...
|
|
|
RE39678 |
Meiosis regulating compounds
Certain novel sterol derivatives can be used for regulating the meiosis in oocytes and in male germ cells.
|
|
|
7217422 |
Compositions and methods for enhancing corticosteroid delivery
The present invention comprises a composition, method of enhancing potency and method of delivering corticosteroids in a vehicle comprising at least two penetration enhancers, and solvents and...
|
|
|
7211246 |
Compositions comprising oestrone-3-0-sulphamate and trail (TNF-related apoptosis inducing ligand)
The present invention provides a composition comprising (i) a compound comprising a sulphamate group (“a sulphamate compound”); and (ii) an apoptosis inducer.
|
|
|
7201919 |
Mixture for transdermal delivery of low and high molecular weight compounds
The present invention relates to the discovery of a transdermal delivery system that can deliver high molecular weight pharmaceuticals and cosmetic agents to skin cells. A novel transdermal...
|
|
|
7198808 |
Process for extracting compounds from plants
The present invention provides a method for selectively extracting acidic and/or non-acidic compounds from natural material such as plant tissue.
|
|
|
7196074 |
Methods of making, using and pharmaceutical formulations comprising 7α, 11β-dimethyl-17β-hydroxyestra-4, 14-dien-3-one and 17 esters thereof
Methods of using 7α,11β-dimethyl-17β-hydroxyestra-4,14-dien-3-one (III)
and 17 esters thereof for various hormonal therapies, oral and parenteral dosage forms comprising these actives, and...
|
|
|
7182956 |
Stable topical drug delivery compositions
A stable composition of a drug comprising a carrier having a phosphatidylcholine component which entraps the drug is applied to the skin for transdermal delivery of the drug.
|
|
|
7179798 |
Methods and compositions for the treatment of pain and other hormone-allergy-related symptoms using dilute hormone solutions
A method and composition for the treatment of hormone allergy is disclosed. The method relates to using progesterone dilutions, or any other steroid hormone, to treat the systemic symptoms of...
|
|
|
7144875 |
Methods of treating fungal infections using lupeol
The invention is directed to methods of treating fungal and yeast infections using lupeol or solvates, hydrates, or clathrates thereof. The method also encompasses methods of treating fungal and...
|
|
|
7129231 |
Regulation of intracellular glucocorticoid concentrations
This invention relates to the interconversion of inactive 11-keto steroids with their active 11B-hydroxy equivalents, to methods by which the conversion of the inactive to the active form may be...
|
|
|
7122533 |
Cosalane compounds and methods for their use
The present invention relates to methods, compounds and compositions for inhibiting effective binding of a chemokine to its cellular receptor. In one form of the invention, a method includes...
|
|
|
7122532 |
Regulation of intracellular glucocorticoid concentrations
This invention relates to the interconversion of inactive 11-keto steroids with their active 11B-hydroxy equivalents, to methods by which the conversion of the inactive to the active form may be...
|